autologous T cell therapy (Somatix)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameautologous T cell therapy (Somatix)
Drug Alias NameT-bodies (Baxter)T-bodies (Somatix)cancer therapy (Somatix)
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSomatix Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSomatix IncBaxter Healthcare Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A